JAK2 Essential Thrombocythemia (ET) Treatment
I recently came upon a fairly recent article about the monoclonal antibody INCA44989 treatment for JAK2 ET. It supposedly has a roughly 70% positive response rate, and with a low toxicity profile, meaning minimal side affects. This is great news for all of us who have been afflicted with this unfortunate blood disorder.
I searched for a discussion about this but nothing came up. I'm wondering if anyone reading this may have some experience or information on this subject.
Thanks
Interested in more discussions like this? Go to the Blood Cancers & Disorders Support Group.
Connect

@gigi05
Many oncologists say that anyone with a platelet count above the normal range (and "normal" varies with where you live in the world) and who is 65 years or older, has a high risk of strokes and heart attacks.
The way I look at it, that MAY not be true for me personally -- but it motivates me to minimize that risk.